Effects of weight reduction with orlistat on cardiovascular risk in obese hyertensive patients with type 2 diabetes

被引：0
|
作者：
Uehara, MH [1 ]
Peres, RB [1 ]
Ferreira, SRG [1 ]
Zanella, MT [1 ]
机构：
[1] Univ Fed Sao Paulo, Sao Paulo, Brazil
来源：
HYPERTENSION | 2001年 / 37卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：1042 / 1042
页数：1
相关论文
共 50 条
  • [31] Economic Evaluation of Orlistat in Overweight and Obese Patients with Type 2 Diabetes Mellitus
    Andreas Maetzel
    Jörg Ruof
    Melva Covington
    Anne Wolf
    PharmacoEconomics, 2003, 21 : 501 - 512
  • [32] Cardiovascular risk in obese and nonobese patients with type 2 diabetes in the West Indies
    Ezenwaka, CE
    Offiah, NV
    JOURNAL OF BIOMEDICAL SCIENCE, 2001, 8 (04) : 314 - 320
  • [33] Effect of Orlistat on cardiovascular risk factors and insulin sensitivity in young obese Chinese type 2 diabetic patients
    Chan, JCN
    Tong, PC
    Lee, ZSK
    Ko, GTC
    Sea, MMM
    Ma, RC
    So, WY
    Chan, WB
    Ozaki, R
    Chow, CC
    Critchley, JAJH
    Cockram, CS
    DIABETES, 2001, 50 : A108 - A108
  • [34] Relationship between cardiovascular fitness and cardiovascular risk among obese patients with type 2 diabetes
    Dasgupta, K
    Grover, SA
    Lowensteyn, I
    Chan, D
    Rahme, E
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2004, 36 (05): : S141 - S141
  • [35] Relationship between cardiovascular fitness and cardiovascular risk among obese patients with type 2 diabetes
    Dasgupta, K
    Grover, S
    Lowensteyn, I
    Rahme, E
    DIABETES, 2004, 53 : A486 - A486
  • [36] Weight management tor type 2 diabetes mellitus: Global cardiovascular risk reduction
    Lee, Michelle
    Aronne, Louis J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (4A): : 68B - 79B
  • [37] CARDIOVASCULAR RISK AND TYPE 2 DIABETES MELLITUS RISK IN OBESE CHILDREN
    Maldonado, J.
    Rubio, N.
    Yafi, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A238 - A238
  • [38] Orlistat promotes glucemia control and other cardiovascular risk factors lowering in obese patients with type 2 diabetes. Randomised clinical trial.
    Hawkins, F
    Duran, S
    Vilardell, E
    Soriguer, F
    Cabezas, J
    Escobar, F
    Miralles, JM
    Faure, E
    Bellido, D
    Herrera, JL
    Serrano-Rios, M
    Tebar, J
    Freijane, J
    Armero, F
    DIABETOLOGIA, 2000, 43 : A171 - A171
  • [39] Modelisation of the 10-year incidence reduction of coronary events in obese Type 2 diabetes patients treated with Orlistat
    Guy-Grand, B
    Valensi, P
    Joubert, JM
    Eschwege, E
    Amouyel, P
    Fagnani, F
    DIABETES, 2002, 51 : A471 - A472
  • [40] Orlistat in the treatment of overweight or obese Chinese patients with newly diagnosed Type 2 diabetes
    Shi, YF
    Pan, CY
    Hill, J
    Gao, Y
    DIABETIC MEDICINE, 2005, 22 (12) : 1737 - 1743
12345